← Thomas Pilgrim

Papers by Thomas Pilgrim

Page 4 · newest first

151. Mid-term outcome of children with latent rheumatic heart disease in eastern NepalOpen Heart · 2021
152. Single antiplatelet therapy with use of prasugrel in patients undergoing percutaneous coronary interventionCatheterization and Cardiovascular Interventions · 2021
153. One-Year Outcomes of a Randomized Trial Comparing a Self-Expanding With a Balloon-Expandable Transcatheter Aortic ValveCirculation · 2021
154. Biodegradable- Versus Durable-Polymer Drug-Eluting Stents for STEMIJACC: Cardiovascular Interventions · 2021
155. Effectiveness of Systematic Echocardiographic Screening for Rheumatic Heart Disease in Nepalese SchoolchildrenJAMA Cardiology · 2021
156. Transvalvular Gradients for Balloon-Expandable and Self-Expanding Valves˜The œJournal of invasive cardiology/˜The œjournal of invasive cardiology · 2020
157. The relationship between baseline diastolic dysfunction and postimplantation invasive hemodynamics with transcatheter aortic valve replacementClinical Cardiology · 2020
158. Antidepressant Treatment in Patients Following Acute Coronary Syndromes: A Systematic Review and Bayesian Meta-AnalysisESC Heart Failure · 2020
159. Validation of high bleeding risk criteria and definition as proposed by the academic research consortium for high bleeding riskEuropean Heart Journal · 2020
160. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scoresEuroIntervention · 2020
161. HAS-BLED score and actual bleeding in elderly patients undergoing transcatheter aortic valve implantationMinerva Medica · 2020
162. Imaging and Patient Selection for Transcatheter Tricuspid Valve InterventionsFrontiers in Cardiovascular Medicine · 2020
163. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990–2017Circulation · 2020
164. Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registryEuroIntervention · 2020
165. Five‐Year Outcomes in Patients With Diabetes Mellitus Treated With Biodegradable Polymer Sirolimus‐Eluting Stents Versus Durable Polymer Everolimus‐Eluting StentsJournal of the American Heart Association · 2019
166. Infective Endocarditis Following Transcatheter Aortic Valve ReplacementCirculation Cardiovascular Interventions · 2019
167. Percutaneous Mitral Edge-to-Edge Repair: State of the Art and a Glimpse to the FutureFrontiers in Cardiovascular Medicine · 2019
168. Does isolated mitral annular calcification in the absence of mitral valve disease affect clinical outcomes after transcatheter aortic valve replacement?European Heart Journal - Cardiovascular Imaging · 2019
169. Prevalence and Evolution of Susceptibility‐Weighted Imaging Lesions in Patients With Artificial Heart ValvesJournal of the American Heart Association · 2019
170. Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary InterventionCirculation Cardiovascular Interventions · 2019
171. Case report of simultaneous transcatheter mitral valve-in-valve implantation and percutaneous closure of two paravalvular leaksEuropean Heart Journal - Case Reports · 2019
172. Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration)European Heart Journal · 2019
173. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysisEuropean Heart Journal · 2019
174. Impact of left ventricular function on clinical outcomes among patients with coronary artery diseaseEuropean Journal of Preventive Cardiology · 2019
175. Twenty-Year Trends in the Incidence and Outcome of Cardiogenic Shock in AMIS Plus RegistryCirculation Cardiovascular Interventions · 2019
176. Interventional treatment of mitral valve regurgitation: an alternative to surgery?Swiss Medical Weekly · 2019
177. Valvular Resistance and Bleeding Events Among Patients Undergoing Transcatheter Aortic Valve ReplacementStructural Heart · 2019
178. Mechanical complications in patients with ST-segment elevation myocardial infarction: A single centre experiencePLoS ONE · 2019
179. Prognostic Relevance of Left Ventricular Myocardial Performance After Transcatheter Aortic Valve ReplacementCirculation Cardiovascular Interventions · 2019
180. Baseline Troponin T level in stroke and its association with stress cardiomyopathyPLoS ONE · 2018
181. Percutaneous patent foramen ovale closure during live case demonstrationsCatheterization and Cardiovascular Interventions · 2018
182. Transcatheter aortic valve replacement in patients with concomitant mitral stenosisEuropean Heart Journal · 2018
183. Temporal trends in adoption and outcomes of transcatheter aortic valve implantation: a SwissTAVI Registry analysisEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2018
184. Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary RevascularizationCirculation Cardiovascular Interventions · 2018
185. A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trialEuroIntervention · 2018
186. Current state of alternative access for transcatheter aortic valve implantationEuroIntervention · 2018
187. Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical PracticeCirculation Cardiovascular Interventions · 2018
188. Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST‐Elevation Myocardial InfarctionJournal of the American Heart Association · 2018
189. Expansion of transcatheter aortic valve implantation: new indications and socio-economic considerationsEuropean Heart Journal · 2018
190. Can bioprosthetic valve thrombosis be promoted by aortic root morphology? An in vitro study†Interactive Cardiovascular and Thoracic Surgery · 2018
191. Early Detection of Subclinical Myocardial Damage in Chronic Aortic Regurgitation and Strategies for Timely Treatment of Asymptomatic PatientsCirculation · 2018
192. Early versus newer generation devices for transcatheter aortic valve implantation in routine clinical practice: a propensity score matched analysisOpen Heart · 2018
193. New-onset arrhythmias following transcatheter aortic valve implantation: a systematic review and meta-analysisHeart · 2017
194. Predicting Mortality After Transcatheter Aortic Valve ReplacementCirculation Cardiovascular Interventions · 2017
195. Coronary artery disease and myocardial revascularization in patients undergoing transcatheter aortic valve replacementJournal of Thoracic Disease · 2017
196. Dual antiplatelet therapy for secondary prevention of coronary artery diseaseOpen Heart · 2017
197. Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectivesExpert Review of Medical Devices · 2017
198. Transcatheter aortic valve thrombosis: incidence, clinical presentation and long-term outcomesEuropean Heart Journal - Cardiovascular Imaging · 2017
199. Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantationEuroIntervention · 2017
200. Type 2 myocardial infarctionJournal of Cardiovascular Medicine · 2017